“Underpowered” Trials Unethical Unless In Early Phase Or Meta-Study – JAMA
This article was originally published in The Tan Sheet
Executive Summary
Early-phase "underpowered" clinical trials of drugs can be considered ethical only if designed to guide later pivotal studies, Scott Halpern, University of Pennsylvania School of Medicine, et al., write in the July 17 Journal of the American Medical Association
You may also be interested in...
Age-Related Macular Degeneration Not Slowed By Vitamin E Regimen – Study
Vitamin E supplementation does not prevent the development or progression of age-related macular degeneration (AMD), according to a study conducted by Hugh Taylor, University of Melbourne, et al.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands